본문 바로가기

Blood component ridable and CD44 receptor targetable nanoparticles based on a maleimide-functionalized chondroitin sulfate derivative

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
CARBOHYDRATE POLYMERS230 · 2020
피인용
Web of Science 29Scopus 31
FWCI (Scopus)
0
JCR IF
JCR 2019 7.182
ISSN
0144-8617

저자

  1. Lee, Jae-Young제1저자College of Pharmacy, Chungnam National University, Daejeon, 34134, Republic of Korea
  2. Lee, Han SolCollege of Pharmacy, Chungnam National University, Daejeon, 34134, Republic of Korea
  3. Kang, Nae-WonCollege of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea
  4. Lee, Song YiCollege of Pharmacy, Kangwon National University, Chuncheon, 24341, Republic of Korea
  5. Kim, Dong HyunCollege of Pharmacy, Chungnam National University, Daejeon, 34134, Republic of Korea
  6. Kim, SungyunCollege of Pharmacy, Kangwon National University, Chuncheon, 24341, Republic of Korea
  7. 윤인수Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan, 46241, Republic of Korea
  8. Cho, Hyun-Jong교신저자College of Pharmacy, Kangwon National University, Chuncheon, 24341, Republic of Korea
  9. Kim, Dae-DukCollege of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea

초록

Chondroitin sulfate A-deoxycholic acid-polyethylene glycol-maleimide (CSA-DOCA-PEG-MAL; CDPM) nanostructures were designed for the transient binding of MAL with thiol in blood components and cell membranes, in addition to the CD44 receptor targeting, for the therapy of breast cancer. The spontaneous binding of free thiol groups in plasma proteins and blood cells with the MAL group of CDPM was significantly higher than that of CSA-DOCA-PEG (CDP). Enhanced cellular uptake and the in vitro antiproliferation efficacy of docetaxel (D)-loaded CDPM (CDPM/D) nanoparticles (NPs) in MCF-7 cells indicated dual-targeting effects based on MAL-thiol reactions and CSA-CD44 receptor interactions. Following intravenous injection in rats, reduced clearance and an elevated half-life of the drug was observed in the CDPM/D NPs compared to the CDP/D NPs. Taken together, MAL modification of CDP NPs could be a promising approach not only to enhance tumor targeting and penetration but also to extend the blood circulation time of anticancer drugs.

키워드

CD44 receptorMaleimide-thiol reactionNanoparticlesTemporary bindingTumor penetrationSELF-ASSEMBLED NANOPARTICLESDRUG-DELIVERYDUAL-LIGANDTUMORPHARMACOKINETICSNANOASSEMBLIESTHERAPEUTICSNANOCARRIERSCIRCULATIONSTRATEGIES

식별자

Scopus EID
2-s2.0-85075538311
WoS UID
000504402300013